Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical and laboratory experience of vorinostat (suberoylanilide hydroxamic acid) in the treatment of cutaneous T-cell lymphoma
Madeleine Duvic, C‐N Zhang
British Journal of Cancer (2006) Vol. 95, Iss. S1, pp. S13-S19
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Histone deacetylase inhibitors: molecular mechanisms of action
Weisheng Xu, Raphael B. Parmigiani, P A Marks
Oncogene (2007) Vol. 26, Iss. 37, pp. 5541-5552
Closed Access | Times Cited: 1478
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistance
Jennifer S. Carew, Steffan T. Nawrocki, Charissa N. Kahue, et al.
Blood (2007) Vol. 110, Iss. 1, pp. 313-322
Open Access | Times Cited: 481
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
Madeleine Duvic, Jenny Vu
Expert Opinion on Investigational Drugs (2007) Vol. 16, Iss. 7, pp. 1111-1120
Closed Access | Times Cited: 325
Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire
Steven Le Gouill, Nöel Milpied, Agnès Buzyn, et al.
Journal of Clinical Oncology (2008) Vol. 26, Iss. 14, pp. 2264-2271
Open Access | Times Cited: 293
Cancer epigenetics: linking basic biology to clinical medicine
Hsing-Chen Tsai, Stephen B. Baylin
Cell Research (2011) Vol. 21, Iss. 3, pp. 502-517
Open Access | Times Cited: 281
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)
Joey L. Methot, Prasun K. Chakravarty, Mélissa Chénard, et al.
Bioorganic & Medicinal Chemistry Letters (2007) Vol. 18, Iss. 3, pp. 973-978
Closed Access | Times Cited: 173
HDAC inhibitor-based therapies and haematological malignancy
Lindsay Stimson, Victoria Wood, Omar Khan, et al.
Annals of Oncology (2009) Vol. 20, Iss. 8, pp. 1293-1302
Open Access | Times Cited: 130
Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis
Susan Fotheringham, Mirjam T. Epping, Lindsay Stimson, et al.
Cancer Cell (2009) Vol. 15, Iss. 1, pp. 57-66
Open Access | Times Cited: 127
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure
Yu‐Hsun Kao, Jing‐Ping Liou, Cheng-Chich Chung, et al.
International Journal of Cardiology (2013) Vol. 168, Iss. 4, pp. 4178-4183
Closed Access | Times Cited: 88
Novel epigenetic therapeutic strategies and targets in cancer
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 12, pp. 166552-166552
Open Access | Times Cited: 29
Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas
Omar Khan, Nicholas B. La Thangue
Nature Clinical Practice Oncology (2008) Vol. 5, Iss. 12, pp. 714-726
Closed Access | Times Cited: 86
Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells
Ann M. Gillenwater, Meiling Zhong, Reuben Lotan
Molecular Cancer Therapeutics (2007) Vol. 6, Iss. 11, pp. 2967-2975
Closed Access | Times Cited: 78
The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells
Ke Long Jin, Jeong‐Yeol Park, Eun Joo Noh, et al.
Journal of Gynecologic Oncology (2010) Vol. 21, Iss. 4, pp. 262-262
Open Access | Times Cited: 68
Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures
Jihong Xu, Deepa Sampath, Frederick F. Lang, et al.
Journal of Neuro-Oncology (2011) Vol. 105, Iss. 2, pp. 241-251
Open Access | Times Cited: 43
Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents
Alfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, et al.
Recent Patents on Anti-Cancer Drug Discovery (2007) Vol. 2, Iss. 2, pp. 119-134
Closed Access | Times Cited: 51
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2)
Joey L. Methot, Christopher L. Hamblett, Dawn M. Mampreian, et al.
Bioorganic & Medicinal Chemistry Letters (2008) Vol. 18, Iss. 23, pp. 6104-6109
Closed Access | Times Cited: 43
Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome
Madeleine Duvic
Hematology (2015) Vol. 2015, Iss. 1, pp. 529-544
Open Access | Times Cited: 17
Design and synthesis of parthenolide-SAHA hybrids for intervention of drug-resistant acute myeloid leukemia
Weizhi Ge, Zhong‐Quan Liu, Yu Sun, et al.
Bioorganic Chemistry (2019) Vol. 87, pp. 699-713
Closed Access | Times Cited: 16
Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2)
Richard W. Heidebrecht, Mélissa Chénard, Joshua Close, et al.
Bioorganic & Medicinal Chemistry Letters (2009) Vol. 19, Iss. 7, pp. 2053-2058
Closed Access | Times Cited: 20
Pharmacophore Identification of Hydroxamate HDAC 1 Inhibitors
Liqin Yu, Fei Liu, Yadong Chen, et al.
Chinese Journal of Chemistry (2009) Vol. 27, Iss. 3, pp. 557-564
Closed Access | Times Cited: 10
Forecasting Gastric Cancer Diagnosis, Prognosis, and Drug Repurposing with Novel Gene Expression Signatures
Talip Yasir Demirtas, Md Rezanur Rahman, Merve Çapkın Yurtsever, et al.
OMICS A Journal of Integrative Biology (2021) Vol. 26, Iss. 1, pp. 64-74
Closed Access | Times Cited: 8
Histone Deacetylase Inhibitors
Philip Jones
Methods and principles in medicinal chemistry (2009), pp. 185-223
Closed Access | Times Cited: 5
Early diagnosis of melanoma: what do we know?
Elliott Yee, Richard M. Hoffman, Marianne Berwick
(2007)
Closed Access | Times Cited: 5
Synthesis, Characterization and Biological Evaluation of Novel Dihydropyranoindoles Improving the Anticancer Effects of HDAC Inhibitors
Murat Bingül, Greg M. Arndt, Glenn M. Marshall, et al.
Molecules (2020) Vol. 25, Iss. 6, pp. 1377-1377
Open Access | Times Cited: 4
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
Madeleine Duvic
Humana Press eBooks (2013), pp. 287-329
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top